Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'
A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).
According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.
THIS IS A BREAKING STORY. UPDATES SOON
Mumbai's Poonawalla Vision Fund Secures ₹1,000 Crore Close, Sees Ultra-High Net Worth Individuals
Indian Rupee: From Stability To Storm in 2025, How The Rupee Slipped Past 91 & Lost Its Asian Strength
Mumbai Court Ends 15-Year Legal Battle, Restores NRI's Ownership Of Illegally Resold Flat
Mumbai's Bora Bora Restaurant Fined ₹50,000 For Levying Service Charge By Default On Bills
